Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson`s Disease Patients With Motor Fluctuations

Study:

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson`s Disease Patients With Motor Fluctuations

Rationale:

n/a

Purpose:

This is a multi-center, randomized, double-blind, placebo-controlled, parallel-group study of E2007 in levodopa treated Parkinson`s disease patients with motor fluctuations.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Parkinson`s Disease Drug: 2 mg perampanel
Drug: 4 mg perampanel
Drug: placebo comparator
Phase 3

Verified by Eisai Inc. January, 2013

Sponsored by: Eisai Inc.
Information provided by: Eisai Inc.
ClinicalTrials.gov identifier: NCT00368108

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Cleveland Clinic Florida - Weston
Weston, Florida 33331
United States

David Squillacote, M.D.., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site